OneMedRadio is steadily filling the pipeline with candid interviews with CEOs of some of the most interesting and innovative micro-cap healthcare and life science companies from around the globe. These companies, often undervalued, have promising futures ahead with many of them appearing at the 5th Annual OneMedForum, January 9-12th in San Francisco. Mark your calendar.
In this issue:
DATATRAK [DATA] continues its recovery with its highest quarterly sales since 2008. Our interview with CEO Larry Birch describes the continued progress for this provider of advanced software systems for the clinical trials industry. In addition, we have a conversation with Frank Reynolds, CEO of InVivo [NVIV], which continues to make progress on its treatment for paralysis. Zacks recently initiated coverage on InVivo with an Outperform rating and $4.00 target.
Other news in this issue:
NYBA announces 2011 Dog Days of Summer Networker at The Dream Hotel. Nanovericides [OTC BB: NNVC.OB]